Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation is a research paper published in Kidney International Reports (2020). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K23 DK117014
National Institutes of Health
Grant: K24 DK078772
National Institutes of Health
Grant: 1K23DK117014-01
Effect of Hepatitis C Virus Eradication on Chronic Kidney Disease Progression
National Institutes of Health
Grant: 5K24DK078772-02
Patient-Oriented Research on Hepatitis in Special Populations
Merck Sharp and Dohme
Massachusetts General Hospital
University of Pennsylvania
FWCI
1.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals